+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis



The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis



Liver International 38(12): 2329-2339



Endoscopic retrograde cholangiography (ERCP) has been considered the gold standard for the diagnosis and follow-up of primary sclerosing cholangitis, but it has been replaced by less invasive magnetic resonance imaging and cholangiopancreatography (MRI-MRCP). However, the role of these two techniques in the evaluation of disease activity and severity needs to be elucidated. Patients with primary sclerosing cholangitis (n: 48, male 31, median age: 35.7; 28.0-44.2) who underwent ERCP and MRI-MRCP within ±3 months for diagnosis or follow-up, were reviewed. ERCP and MRI-MRCP images were scored using the modified Amsterdam score. Serum and biliary cytology markers of disease activity and severity were related to the imaging findings. Agreement on the assessment of the ERCP/MRCP score was calculated by kappa-statistics. Spearman's ρ was calculated when appropriate. The agreement between ERCP and MRCP in scoring bile duct changes for disease severity was only moderate (weighted kappa: 0.437; 95% CI: 0.211-0.644 for intra- and 0.512; 95% CI: 0.303-0.720 for extra-hepatic bile ducts). ERCP and MRCP intra-hepatic scores were associated to the surrogate marker alkaline phosphatase (P = .02 for both). A weak correlation between MRCP score for extra-hepatic bile ducts and liver transplantation/death was found (Spearman's ρ = .362, 95% CI: 0.080-0.590, P = .022). A weak correlation between intra- (Spearman's ρ = .322, 95% CI: 0.048-0.551, P = .022) and extra-hepatic (Spearman`s ρ = .319, 95% CI: 0.045-0.549, P = .025) peribiliary enhancement on contrast-enhanced MRI and severity of biliary cytologic classification was found. The overall agreement between ERCP and MRI-MRCP in assessing disease severity was moderate for intra- and extra-hepatic bile ducts. MRI-MRCP seems to have a minor role as surrogate marker of disease activity and progression in PSC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065612094

Download citation: RISBibTeXText

PMID: 29901259

DOI: 10.1111/liv.13899


Related references

Magnetic resonance cholangiography compared with endoscopic retrograde cholangiography in the diagnosis of primary sclerosing cholangitis. Journal of Research in Medical Sciences 19(12): 1150-1154, 2014

Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointestinal Endoscopy 64(2): 219-223, 2006

Magnetic resonance cholangiography vs endoscopic retrograde cholangiography for diagnosis of primary sclerosing cholangitis A blinded case controlled study. Gastroenterology 116(4 Part 2): A9, 1999

Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clinical Gastroenterology and Hepatology 4(4): 514-520, 2006

Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 34(12): 984-990, 2002

Co19 Blinded Comparative Study Of Magnetic Resonance Cholangiography (Mrc) Versus Endoscopic Retrograde Cholangiography (Erc) In The Diagnosis Of Sclerosing Cholangitis (Sc) In Children. Digestive and Liver Disease 44: S248-S249, 2012

Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiologica 54(6): 601-607, 2013

Comparison of 3D-IR-TSE-MR-cholangiography with endoscopic retrograde cholangiography in the evaluation of primary sclerosing cholangitis. Gastroenterology 112(4 Suppl. ): A1400, 1997

Magnetic resonance cholangiography in patients with biliary disease: Its role in primary sclerosing cholangitis. Journal of Hepatology 33(4): 520-527, 2000

The role of endoscopic retrograde cholangiography in the diagnosis and management of patients with primary sclerosing cholangitis. Clinical Radiology 30(4): 445-450, 1979

Diagnosis of primary sclerosing cholangitis: prospective comparison of MR cholangiography with endoscopic retrograde cholangiography. Rofo 169(6): 622-626, 1998

The role of magnetic resonance cholangiography in primary sclerosing cholangitis. Journal of Hepatology 33(4): 659-660, 2000

Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clinical Gastroenterology and Hepatology 9(9): 800-803.E2, 2011

Endoscopic retrograde cholangiography in primary sclerosing cholangitis a risk. Journal of Hepatology 11(Suppl. 2): S74, 1990

Economic Appraisal Of The Role Of Magnetic Resonance Cholangiography In The Diagnosis Of Primary Sclerosing Cholangitis. Evidence-Based Gastroenterology 5(4): 120-121, 2004